DA32 Life Science Tech Acquisition Corp. Quarterly Operating Income (Loss) in USD from Q2 2021 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
DA32 Life Science Tech Acquisition Corp. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2021 to Q1 2023.
  • DA32 Life Science Tech Acquisition Corp. Operating Income (Loss) for the quarter ending March 31, 2023 was -$412K, a 23.5% decline year-over-year.
  • DA32 Life Science Tech Acquisition Corp. Operating Income (Loss) for the twelve months ending March 31, 2023 was -$1.84M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$1.84M -$412K -$78.5K -23.5% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-12
Q4 2022 -$1.76M -$387K Oct 1, 2022 Dec 31, 2022 10-K 2023-03-29
Q3 2022 -$428K -$147K -52.3% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 -$612K -$570K -1335% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-15
Q1 2022 -$333K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q3 2021 -$281K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$42.7K Apr 16, 2021 Jun 30, 2021 10-Q 2022-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.